F
Feng Shen
Researcher at Second Military Medical University
Publications - 403
Citations - 12498
Feng Shen is an academic researcher from Second Military Medical University. The author has contributed to research in topics: Hepatocellular carcinoma & Medicine. The author has an hindex of 46, co-authored 313 publications receiving 8315 citations.
Papers
More filters
Journal ArticleDOI
Treatment of portal vein tumor thrombus of hepatocellular carcinoma with percutaneous laser ablation
TL;DR: Wang et al. as mentioned in this paper evaluated the application of percutaneous laser ablation as a treatment for portal vein tumor thrombus (PVTT) due to advanced hepatocellular carcinoma.
Journal ArticleDOI
Survival benefits from adjuvant transcatheter arterial chemoembolization in patients undergoing liver resection for hepatocellular carcinoma: a systematic review and meta-analysis:
Lei Liang,Chao Li,Yong-Kang Diao,Hang-Dong Jia,Hao Xing,Timothy M. Pawlik,Wan Yee Lau,Feng Shen,Dong-Sheng Huang,Cheng-Wu Zhang,Tian Yang +10 more
TL;DR: Postoperative adjuvant TACE may be effective to improve OS and DFS in patients with multinodular HCC, or HCC with MVI or PVTT, but not among patients with large HCC (⩾5 cm).
Journal ArticleDOI
A novel online calculator based on noninvasive markers (ALBI and APRI) for predicting post-hepatectomy liver failure in patients with hepatocellular carcinoma
Jin-yu Shi,Li-Yang Sun,Bing Quan,Hao Xing,Chao Li,Lei Liang,Timothy M. Pawlik,Ya-Hao Zhou,Hong Wang,Wei-Min Gu,Ting-Hao Chen,Wan Yee Lau,Feng Shen,Nan-Ya Wang,Tian Yang +14 more
TL;DR: ALBI and APRI demonstrated more accurate ability to predict PHLF than Child-Pugh and MELD, and two online calculators were proposed as useful preoperative and postoperative tools for individually predicting the occurrence of PHLf among patients with HCC.
Journal ArticleDOI
Enhancement of immunogenicity of tumor cells by cotransfection with genes encoding antisense insulin-like growth factor-1 and B7.1 molecules
Yanjun Liu,Hao Wang,Jian Zhao,Jian Zhao,Jing Ma,Jing Ma,Lixin Wei,Shuguang Wu,Tianpei Xie,Feng Shen,Jerzy Trojan,Nagy A. Habib,Donald D. Anthony,Meng-Chao Wu,Yajun Guo +14 more
TL;DR: It is reported that the immunogenicity of hepa 1–6 hepatoma and SMCC-1 colon carcinoma cells, which are poorly immunogenic and unresponsive to antisense IGF-1 gene transfer, can be induced by cotransfection with genes encoding antisense FIA-1 and mouse B7.1 molecules.
Journal ArticleDOI
Clinical performance of α-L-fucosidase for early detection of hepatocellular carcinoma.
Hao Xing,Hai-Bo Qiu,Xuemei Ding,Jun Han,Zhen-Li Li,Han Wu,Cunling Yan,Huijun Li,Ruilin Han,Han Zhang,Chao Li,Ming-Da Wang,Meng-Chao Wu,Feng Shen,Yijie Zheng,Tian Yang +15 more
TL;DR: AFU is a suboptimal biomarker for early detection of HCC and the AUC of AFU alone or the combination with AFP were lower than that of AFP alone.